Data / Form D filings / Monocacy Therapeutics Inc.
Monocacy Therapeutics Inc.: Form D filing
Monocacy Therapeutics Inc., a biotechnology company in Monrovia, MD, filed a Form D with the SEC in 2026. The latest, on October 7, 2026, reports $25,000 sold of a $25,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4716 MONROVIA BLVD, Monrovia, MD, 21770
- Phone
- (301) 979-0911
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2137361
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7 | New notice | $25,000 | $25,000 | 1 | Sep 25 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Suman Vodnala | Executive Officer | |
| Shashank Patel | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Kaigene, Inc. $55 million · Oct 14
- Templar Nova, Inc. $7 million · Oct 7
Every Form D from the week of Oct 5 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Monocacy Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.